JP2025510414A5 - - Google Patents
Info
- Publication number
- JP2025510414A5 JP2025510414A5 JP2025502799A JP2025502799A JP2025510414A5 JP 2025510414 A5 JP2025510414 A5 JP 2025510414A5 JP 2025502799 A JP2025502799 A JP 2025502799A JP 2025502799 A JP2025502799 A JP 2025502799A JP 2025510414 A5 JP2025510414 A5 JP 2025510414A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- compound
- pharmaceutically acceptable
- acceptable salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/704,983 US11618751B1 (en) | 2022-03-25 | 2022-03-25 | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US17/704,983 | 2022-03-25 | ||
| US202263420930P | 2022-10-31 | 2022-10-31 | |
| US63/420,930 | 2022-10-31 | ||
| US202363443874P | 2023-02-07 | 2023-02-07 | |
| US63/443,874 | 2023-02-07 | ||
| PCT/US2023/064967 WO2023183943A1 (en) | 2022-03-25 | 2023-03-24 | Pyrido-[3,4-d]pyridazine amine derivatives useful as nlrp3 derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510414A JP2025510414A (ja) | 2025-04-14 |
| JP2025510414A5 true JP2025510414A5 (https=) | 2026-04-02 |
Family
ID=86329581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025502799A Pending JP2025510414A (ja) | 2022-03-25 | 2023-03-24 | ＮＬＲＰ３誘導体として有用なピリド－［３，４－ｄ］ピリダジンアミン誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4499638A1 (https=) |
| JP (1) | JP2025510414A (https=) |
| KR (1) | KR20250005125A (https=) |
| CN (1) | CN119137121A (https=) |
| AU (1) | AU2023238121A1 (https=) |
| CA (1) | CA3246681A1 (https=) |
| CL (1) | CL2024002855A1 (https=) |
| CO (1) | CO2024013702A2 (https=) |
| IL (1) | IL315842A (https=) |
| MX (1) | MX2024011697A (https=) |
| PE (1) | PE20250605A1 (https=) |
| TW (1) | TW202345836A (https=) |
| WO (1) | WO2023183943A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| TW202313577A (zh) | 2021-06-04 | 2023-04-01 | 瑞士商赫孚孟拉羅股份公司 | 新穎化合物 |
| US12331048B2 (en) * | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| KR20250106322A (ko) * | 2022-12-28 | 2025-07-09 | 장춘 진사이언스 파마슈티컬 씨오., 엘티디. | 피리다진계 nlrp3 억제제 화합물, 약학 조성물 및 이의 제조 방법과 용도 |
| WO2025059481A1 (en) | 2023-09-13 | 2025-03-20 | Ventus Therapeutics U.S., Inc. | Solid forms of an nlrp3 inhibitor and uses thereof |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR119731A1 (es) * | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
| US11618751B1 (en) * | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) * | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| CR20240093A (es) * | 2021-08-25 | 2024-05-23 | Ptc Therapeutics Inc | Inhibidores de NLRP3 |
-
2023
- 2023-03-24 CA CA3246681A patent/CA3246681A1/en active Pending
- 2023-03-24 PE PE2024002059A patent/PE20250605A1/es unknown
- 2023-03-24 WO PCT/US2023/064967 patent/WO2023183943A1/en not_active Ceased
- 2023-03-24 JP JP2025502799A patent/JP2025510414A/ja active Pending
- 2023-03-24 KR KR1020247034096A patent/KR20250005125A/ko active Pending
- 2023-03-24 EP EP23722227.8A patent/EP4499638A1/en active Pending
- 2023-03-24 CN CN202380037553.1A patent/CN119137121A/zh active Pending
- 2023-03-24 TW TW112111280A patent/TW202345836A/zh unknown
- 2023-03-24 AU AU2023238121A patent/AU2023238121A1/en active Pending
- 2023-03-24 IL IL315842A patent/IL315842A/en unknown
-
2024
- 2024-09-24 CL CL2024002855A patent/CL2024002855A1/es unknown
- 2024-09-24 MX MX2024011697A patent/MX2024011697A/es unknown
- 2024-10-10 CO CONC2024/0013702A patent/CO2024013702A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025510414A5 (https=) | ||
| JP2021105032A5 (https=) | ||
| JP5148271B2 (ja) | 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物 | |
| EA016687B8 (ru) | Производные циклопропиламида | |
| JP2013139446A5 (https=) | ||
| See et al. | Choosing a skeletal muscle relaxant | |
| JP2022540935A5 (https=) | ||
| JP2022153638A5 (https=) | ||
| JP2016199576A5 (https=) | ||
| JP2013535437A5 (https=) | ||
| HRP20180487T1 (hr) | Upotreba flekainida kao anti-koneksinskog sredstva i metoda za potenciranje učinaka psihotropnog lijeka | |
| JP2026035701A5 (https=) | ||
| Tsaousi et al. | Implementation of magnesium sulphate as an adjunct to multimodal analgesic approach for perioperative pain control in lumbar laminectomy surgery: a randomized placebo-controlled clinical trial | |
| KR20080103043A (ko) | 우울증 환자에게 있는 수면 장애의 치료를 위해 의도된 치료제를 수득하기 위한 아고멜라틴의 사용 | |
| JP2013541583A5 (https=) | ||
| JP2015500223A5 (https=) | ||
| JP2022539152A5 (https=) | ||
| JP2014523888A5 (https=) | ||
| JP2013537901A5 (https=) | ||
| Rodriguez et al. | ERAS protocols and multimodal pain management in surgery | |
| JP2014530223A5 (https=) | ||
| JP2023518640A5 (https=) | ||
| JP2024543135A5 (https=) | ||
| RU2016104221A (ru) | Имидазолкарбоксамиды и их применение в качестве ингибиторов гидролазы амидов жирных кислот | |
| JP2025506201A5 (https=) |